Non-lethal fetal toxicity of the angiotensin receptor blocker candesartan
Open Access
- 29 June 2006
- journal article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 21 (9), 1329-1330
- https://doi.org/10.1007/s00467-006-0162-y
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonistsEarly Human Development, 2006
- Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertensionCurrent Medical Research and Opinion, 2005
- Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?Journal of Human Hypertension, 2005
- Angiotensin II receptor antagonist treatment during pregnancyBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?Pediatric Nephrology, 2004
- Invited Review Recognition and management of angiotensin converting enzyme inhibitor fetopathyPediatric Nephrology, 1995